Selective serotonin-reuptake inhibitors (SSRIs), or the serotonin-norepinephrine reuptake inhibitor (SNRI) venlafaxine (Effexor, generic), are the primary first-line treatment for anxiety disorders. For patients who are not helped by these drugs or who need help rapidly, benzodiazepines may be prescribed, either alone or in combination with an antidepressant. Other types of antidepressants, including tricyclic antidepressants, may also be used to treat patients with severe or chronic...
Read moreI am bipolar and suffer from various anxieties, and I was thinking recently about the effects each of these conditions has had on me... Read more »
If you're like many of us, you might look over today's dismal economic horizon and often feel as if there's no end in sight. Whether you're... Read more »
A recently published on-line survey commissioned by the Anxiety Disorders Association of America (ADAA) provides up-close and... Read more »
According to The National Institute of Mental Health (NIMH) about 40 million American adults who are 18 and older have an anxiety disorder.... Read more »
There seem to be a lot of news stories about marijuana lately. The New York Times has reported recently that smoking marijuana does not... Read more »
A study presented by Sepracor, maker of Lunesta, indicates that generalized anxiety disorder patients who took the sleep medicine along with Lexapro... Read more »
Researchers at Washington University School of Medicine in St. Louis have found that adults with generalized anxiety disorder (GAD) may be helped by... Read more »
A recent study has found that Ambien CR can help people with insomnia and generalized anxiety disorder fall asleep faster and stay asleep longer.... Read more »
Social anxiety disorder cannot be cured. Medications are available and have been found to be helpful for some people. Medications sometimes will... Read more »
Researchers in Belgium are reporting that Lexapro significantly improves quality of life for patients with major depressive disorder (MDD) and... Read more »